Need Help? Contact us By:
 

 About Us
 Custom Research
 Link to Us
 Free E-Newsletter
 Site Map
 Feedback
 Help and FAQ's

Are You:
- Looking for   Sales Prospects?
- Writing a Business
  Plan?

- Doing Market
  Research?

- Looking for a Job?
- Planning Business   Strategy?
- Studying an Industry
  for Marketing or   Investments?

The business intelligence you need is in Plunkett's almanacs, CD-ROMs and online subscription services.

 Login to Plunkett
 Research Online
 (Subscribers only)


 Get more information
 about Plunkett
 Research Online


 
 Japanese Version
   
Plunkett's Biotech Industry (Summary)


100% Satisfaction Guaranteed

Visit the Health Care and Biotech Industry Channel for more information, statistics and trends.

This book is excerpted from our highly-regarded, comprehensive reference tool: Plunkett's Biotech and Genetics Industry Almanac.

Information about eBook versions of our Almanacs

Secure Online Ordering: (We provide a convenient, secure online ordering system encrypted by VeriSign. If you prefer you may order by calling 713.932.0000.)

Order this eBook (PDF) for immediate download*
Purchase an Online Subscription  


*eBook purchasers will receive an email immediately after their purchase containing a link to the eBook file. The eBook will then be stored on your hard drive for long-term use.

2006 Edition
ISBN 1-59392-711-8
PDF $99.99
41 Pages
August 2005

This report will be your ready-reference guide to the Biotechnology and Genetics Industry. In one carefully-researched report, you'll get all of the data you need. Topics include: 1) A Short History of Biotechnology, 2) The State of the Biotechnology Industry Today, 3) New Money Pours into Biotech Firms, 4) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms, 5) From India to Singapore to Russia, Nations Compete Fiercely in Biotech Development, 6) Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to Medicine, 7) New Kinase Inhibitors Are Breakthrough Drugs for Cancer Treatment—Many More Will Follow, 8) Systems Biology May Lead to Faster, More Cost-Effective Drug Development, 9) Pharmaceutical Costs Soars in U.S., Controversy over Drug Prices Rages On, 10) Stem Cells—Controversy in the U.S. Threatens to Leave America Far Behind in the Research Race, 11) Stem Cell Funding Trickles at the Federal Level While California Creates Funding of Its Own, 12) Stem Cells—Therapeutic Cloning Techniques Advance, 13) Stem Cells—A New Era of Regenerative Medicine Looms, 14) Nanotechnology and Information Technologies Converge with Biotech, 15) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy, 16) Breakthrough Drug Delivery Systems Evolve, 17) Biogenerics are in Limbo in the U.S., 18) HapMap Project Moves Ahead, 19) BioShield Promises $5.6 Billion to Counter Potential Bioterror Attacks in the U.S., 20) Ethical Issues Abound, 21) Technology Discussion—Genomics, 22) Technology Discussion—Proteomics, 23) Technology Discussion—Microarrays, 24) Technology Discussion—DNA Chips, 25) Technology Discussion—SNPs (“Snips”), 26) Technology Discussion—Combinatorial Chemistry, 27) Technology Discussion—Vaccines, 28) Technology Discussion—Synthetic Biology, 29) Technology Discussion—Recombinant DNA, 30) Technology Discussion—Polymerase Chain Reaction (PCR).

 

Home
| About Us | Fax Order Form | Publications | Contact Us
Help | Link to Us | Feedback | Free Newsletters | Custom Research | Site Map | Online Subscriptions | Privacy Policy
Using This Site Means You Accept Its Terms


Copyright ©2001-2005, Plunkett Research, Ltd. All rights reserved.